AI assistant
Sending…
Gain Therapeutics, Inc. — Director's Dealing 2021
Dec 28, 2021
34440_dirs_2021-12-28_f9bb6151-5399-4a06-a71d-e2002ec55ac9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Gain Therapeutics, Inc. (GANX)
CIK: 0001819411
Period of Report: 2021-12-23
Reporting Person: Alder Matthias (N/A)
More from Gain Therapeutics, Inc.
Regulatory Filings
2026
May 26
Proxy Solicitation & Information Statement
2026
Apr 28
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Regulatory Filings
2026
Mar 18
Investor Presentation
2026
Feb 3
Regulatory Filings
2025
Dec 18
Regulatory Filings
2025
Dec 3
Capital/Financing Update
2025
Nov 28
Capital/Financing Update
2025
Nov 28